Immunovant Ownership | Who Owns Immunovant?
Immunovant Ownership Summary
Immunovant is owned by 53.69% institutional investors, 55.64% insiders. Fmr is the largest institutional shareholder, holding 8.94% of IMVT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.04% of its assets in Immunovant shares.
IMVT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Immunovant | 53.69% | 55.64% | -9.34% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 13.10M | 8.94% | $324.44M |
Vanguard group | 6.68M | 4.56% | $165.45M |
Deep track capital, lp | 6.00M | 4.10% | $148.62M |
Blackrock | 4.92M | 3.56% | $129.79M |
Blackrock funding, inc. /de | 5.14M | 3.51% | $127.39M |
Armistice capital | 3.40M | 2.46% | $89.68M |
State street | 2.72M | 1.97% | $71.78M |
Viking global investors lp | 2.32M | 1.68% | $61.27M |
Alpine global management | 1.91M | 1.38% | $50.36M |
Woodline partners lp | 1.82M | 1.32% | $48.14M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Alpine global management | 1.91M | 8.76% | $50.36M |
Deep track capital, lp | 6.00M | 5.54% | $148.62M |
Adar1 capital management | 787.48K | 3.90% | $19.51M |
Tyro capital management | 250.62K | 3.00% | $6.62M |
Two seas capital lp | 692.41K | 2.97% | $18.28M |
Prosight management, lp | 325.00K | 2.56% | $8.58M |
Paradigm biocapital advisors lp | 1.36M | 1.38% | $35.98M |
Logos global management lp | 575.00K | 1.22% | $15.18M |
Redmile group | 720.18K | 1.15% | $19.01M |
Boxer capital | 825.00K | 1.15% | $21.78M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | 6.00M | 5.54% | 1.65M |
T. rowe price investment management | 1.63M | 0.03% | 1.63M |
Armistice capital | 3.40M | 1.13% | 1.23M |
Jpmorgan chase | 1.15M | 0.00% | 925.08K |
Norges bank | 637.95K | 0.00% | 637.95K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 asset management | - | - | -1.38M |
Logos global management lp | 575.00K | 1.22% | -1.20M |
Capital research global investors | - | - | -976.24K |
State street | 2.72M | 0.00% | -922.95K |
Commodore capital lp | - | - | -750.99K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
T. rowe price investment management | 1.63M | 0.03% | 1.63M | $42.91M |
Norges bank | 637.95K | 0.00% | 637.95K | $15.80M |
Bnp paribas arbitrage, snc | 85.20K | 0.00% | 85.20K | $2.11M |
Mirae asset global etfs | 32.96K | 0.00% | 32.96K | $867.92K |
Knights of columbus asset advisors | 24.87K | 0.04% | 24.87K | $616.10K |
Sold Out
Holder | Change |
---|---|
Reuter james wealth management | -1.00 |
Capital performance advisors llp | -3.00 |
Nelson, van denburg & campbell wealth management group | -11.00 |
Cibc private wealth group | -17.00 |
Innealta capital | -59.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 204 | -4.23% | 78,645,357 | 5.27% | 53 | 2.05% | 94 | -14.55% | 64 | - |
Jun 30, 2024 | 211 | -10.21% | 74,707,025 | 7.20% | 54 | 2.33% | 109 | 0.93% | 63 | -23.17% |
Mar 31, 2024 | 235 | -7.11% | 69,688,195 | 1.94% | 48 | 2.16% | 108 | -20.00% | 82 | 3.80% |
Dec 31, 2023 | 253 | 18.22% | 68,360,172 | 2.16% | 47 | 1.80% | 135 | 1.50% | 79 | 71.74% |
Sep 30, 2023 | 214 | 36.31% | 66,916,900 | 20.66% | 51 | 2.53% | 133 | 49.44% | 46 | 4.55% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 4.45M | 3.04% | 196.00K |
Fidelity Growth Compy Commingled Pl S | 4.93M | 2.91% | 135.89K |
Fidelity Growth Company Fund | 3.48M | 2.05% | -11.50K |
T. Rowe Price Small-Cap Stock | 2.09M | 1.43% | 207.91K |
T. Rowe Price US Small-Cap Core Equity | 2.09M | 1.43% | 806.13K |
Vanguard Total Stock Mkt Idx Inv | 2.08M | 1.42% | 3.50K |
Vanguard Small Cap Index | 1.68M | 1.15% | 17.95K |
iShares Russell 2000 ETF | 1.58M | 0.93% | -12.05K |
Vanguard Small Cap Value Index Inv | 1.12M | 0.76% | -4.84K |
T. Rowe Price Instl Small-Cap Stock | 1.11M | 0.76% | 172.65K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 22, 2025 | Stout Jay S | Chief Technology Officer | Sell | $51.78K |
Jan 22, 2025 | Geffner Michael | Chief Medical Officer | Sell | $62.68K |
Jan 15, 2025 | Macias William L. | Chief Medical Officer | Sell | $9.21K |
Jan 15, 2025 | Macias William L. | Chief Medical Officer | Sell | $2.27K |
Jan 15, 2025 | Macias William L. | Chief Medical Officer | Sell | $44.83K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 1 | 12 |
2024 Q4 | - | 16 |
2024 Q3 | - | 28 |
2024 Q2 | - | 23 |
2024 Q1 | - | 14 |
IMVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools